{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T10:00:16Z","timestamp":1717754416327},"reference-count":0,"publisher":"American College of Physicians","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.7326\/j22-0077","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T21:00:25Z","timestamp":1664830825000},"page":"JC117","source":"Crossref","is-referenced-by-count":1,"title":["In migraine with previous treatment failures, eptinezumab safely reduced migraine days at 1 to 12 wk"],"prefix":"10.7326","volume":"175","author":[{"given":"John R.","family":"Absher","sequence":"first","affiliation":[{"name":"University of South Carolina School of Medicine, Greenville, South Carolina, USA (J.R.A.)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T21:04:10Z","timestamp":1666040650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/J22-0077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.7326\/J22-0077"],"URL":"https:\/\/doi.org\/10.7326\/j22-0077","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}